Sarah Lau

Partner

Sarah’s client base includes UK and international academic institutes, startups and SMEs as well as large multinationals. For her clients, Sarah handles invention capture, patentability opinions, drafting patent applications, prosecuting those patent applications in Europe and the UK and co-ordinating prosecution strategy on worldwide patent portfolios as well as providing freedom to operate opinions and working on EPO oppositions and appeals.  Sarah has a wealth of experience in patent prosecution and an excellent track record in obtaining allowance of difficult cases. 
 

Sarah’s practice focusses on the field of biotechnology, and she has significant expertise in the areas of synthetic biology, next-generation DNA sequencing technologies, proteomics, diagnostics, pharmaceuticals, medical devices and antibody technology, especially in relation to antibody fragments and therapeutic uses of antibodies. She is particularly interested in technologies where the biotechnology field intersects with other fields. An area of special interest for Sarah is synthetic biology, and she regularly speaks at and attends synthetic biology events.
 

She is experienced in advising in relation to the patentability of diagnostic methods and takes a keen interest in developments in this field in Europe and elsewhere, particularly in the US.
 

Sarah speaks regularly on aspects of European and UK patent practice and IP issues in relation to biotechnology, as well as lecturing patent trainees, IP administrators and paralegals. 

 

Qualifications

European Patent Attorney
Chartered UK Patent Attorney
IP Litigator - Patent
BA (Hons) Natural Sciences (Zoology) - University of Cambridge (2001), specialising in molecular and cellular biology
 

Memberships

Chartered Institute of Patent Attorneys (CIPA)
The Institute of Professional Representatives before the European Patent Office (EPI)
 

Selected Publications

Conversation with Sarah Lau in The Emergence of Life: From Chemical Origins to Synthetic Biology, Second Edition by Pier Luigi Luisi (Cambridge University Press 2016)

IP issues in relation to synthetic biology – presentation at Synthetic Biology Congress (October 2014)

Patent practice in the US post-Myriad – presentation at UK Bioscience Forum (October 2014)

Gene patenting in Europe and the US after Myriad – presentation at UK Bioscience Forum (October 2013)

‘Practical tips for protecting your inventions’, Microbiologist magazine, (March 2013)

  • Biotechnology
  • Medical Devices
  • Biologics
  • Healthcare
  • Patents

The life sciences and chemistry team regularly contributes thoughts and insights to our future thinking.

Read here

Cookies improve the way our website works. By using this website you are agreeing to our use of cookies. For more information see our cookie policy I accept